A walk through the TRIUMPH-1 Phase 3 results for retatrutide, the GLP-1, GIP and glucagon triple agonist.
How do these numbers compare with the published trial? Link the paper or the conference data.
0 comments
A walk through the TRIUMPH-1 Phase 3 results for retatrutide, the GLP-1, GIP and glucagon triple agonist.
How do these numbers compare with the published trial? Link the paper or the conference data.
Log in to join the discussion.